Home > Financial Ratios > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results

FREDUN PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025
   EV/Core EBITDA(x) 11.348.70

What is the latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of FREDUN PHARMACEUTICALS is 11.34 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202611.34
Mar20258.70

How is EV/Core EBITDA of FREDUN PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 11.34
30.34
Mar2025 8.7 -

Other Financial Ratios of FREDUN PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of FREDUN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS ₹2,339.5 Cr -4.2% 3.2% 181.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -0.4% -6.1% 5.5% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr 0.9% -3.3% 39.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr 0.1% -7.2% 28.2% Stock Analytics
CIPLA ₹108,012.0 Cr -0.3% -4% -15.7% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr 1.5% 3.1% 0.4% Stock Analytics


FREDUN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
FREDUN PHARMACEUTICALS

-4.2%

3.2%

181.7%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses